Metformin use is associated with a lower risk of osteoporosis in adult women independent of type 2 diabetes mellitus and obesity. REDLINC IX study

Article

Abstract: Metformin may decrease cell senescence, including bone; hence we aimed at evaluating the association

Palabras claves:

aging, Metformin, OSTEOPOROSIS, Senescence

Autores:

Aedo S., Arriola-Montenegro J., Arteaga E., Belardo A., Eliana Ojeda, Fighera T.M., J. E. Blümel, López M., Mabel T. Martino, Maríá Soledad Vallejo, Miranda C., Mostajo D., Ñañez M., Octavio Miranda, Peter A. Chedraui, Pilnik S., Rojas J.A., Salinas C., Sosa L., Spritzer P.M., Tserotas K.

Fuentes:

scopus